Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
O'Brien Patrick
COO at ARROWHEAD PHARMACEUTICALS. Filing since 18 Jan 2019.
CIK 0001627183
Company
Date
Role
Action
Shares
Amount
Of holding
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
5 Jan 2026
COO
Sold on a plan
49,493
$3.12M
9.4%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
7 Jan 2025
COO and General Counsel
Sold on a plan
8,000
$157.52K
1.5%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
6 Jan 2025
COO and General Counsel
Sold on a plan
29,184
$578.54K
5.2%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
5 Jan 2024
COO and General Counsel
Sold on a plan
22,841
$805.72K
4.7%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
4 Jan 2024
COO and General Counsel
Sold on a plan
1,600
$52.21K
0.4%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
3 Jan 2024
COO and General Counsel
Sold on a plan
8,749
$282.44K
2.1%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
5 Jan 2023
COO and General Counsel
Sold, plan not stated
15,000
$560.85K
3.5%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
3 Jan 2023
COO and General Counsel
Sold, plan not stated
17,500
$670.80K
4.6%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
5 Jan 2022
General Counsel
Sold, plan not stated
32,500
$2.01M
8.5%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
8 Feb 2021
General Counsel
Sold, plan not stated
90,000
$7.96M
23.5%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
6 Jan 2021
General Counsel
Sold, plan not stated
25,000
$1.81M
7.9%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
6 Jan 2020
General Counsel
Sold, plan not stated
14,625
$879.26K
5.4%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
28 May 2019
General Counsel
Sold, plan not stated
30,000
$746.40K
12.9%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
18 Jan 2019
General Counsel
Sold, plan not stated
72,000
$1.04M
23.6%
14 decisions on file.
